Clinical Research Directory

Outcomes of Arterial Allografts Preserved at +2 to +8°C for Revascularization in Septic Settings

Sponsor: Hospices Civils de Lyon

Summary

This study does not modify patient management or treatment. All patients undergoing treatment with an arterial allograft preserved at +2/+8°C as part of an arterial revascularization in a septic environment in either of the two centers between January 2024 and January 2025 will be included. Imaging exams and clinical follow-up data will be analyzed. Reinterventions and causes of death will be recorded. All imaging required for the 6-month follow-up is routinely performed as part of standard care. No modification of patient management is planned.

Official title: Résultats Des Allogreffes artérielles conservée à +2/+8°C Dans Les REvascularisations en MIlieu Septique

Key Details

Conditions

Interventions

Locations (2)